Randomized trial evaluates a new tool for assessing Parkinson's mild cognitive impairment, suggesting effective remote assessment capability.
INTRODUCTION: Recently, research has focused on understanding the assessment and management of Parkinson's Disease Mild Cognitive Impairment (PD-MCI) (Svenningsson et al., 2012). The primary aim of this two-phase study was to develop a novel cognitive assessment tool, Par-Cog (Parkinson's Cognition) designed to evaluate PD-MCI. METHODS: In Phase 1, 20 experts(including Neurologists, Geriatricians, Neuropsychologists, and PD Nurses) were recruited via social media and anonymously completed a survey on Qualtrics, providing feedback on the acceptability and validity of the Par-Cog. The qualitative data were analyzed using the content analysis method proposed by Elo & Kyngäs, 2008, while descriptive statistics analyzed the quantitative data. Phase 2 included 100 cognitively healthy participants from the British Isles, aged between 50 and 79 years, who were randomly assigned to either Group A or Group B (alternating, consecutive order for completing the Par-Cog and Addenbrookes, ACE-III) using Zoom. RESULTS: = .835). CONCLUSION: Although the Par-Cog is still in the early stages of development, this study indicates that it serves as an effective remote assessment tool for evaluating PD-MCI, with constructs of acceptability, validity and reliability examined.
No takes yet. Share an insight, caveat, or question.
Craig et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: